Novartis walks away from 3rd Zolgensma plant just a year after leasing it as it pivots resources to next-gen pipeline
When Novartis leased a facility in Longmont, CO just a year ago from AstraZeneca, it had big plans to ramp up manufacturing for gene therapy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
